Innoviva, Inc. Files 8-K on Financials
Ticker: INVA · Form: 8-K · Filed: Nov 6, 2024 · CIK: 1080014
| Field | Detail |
|---|---|
| Company | Innoviva, INC. (INVA) |
| Form Type | 8-K |
| Filed Date | Nov 6, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, 8-k
TL;DR
Innoviva dropped an 8-K on Nov 6th detailing financial results. Check it out.
AI Summary
Innoviva, Inc. filed an 8-K on November 6, 2024, reporting on its Results of Operations and Financial Condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 1350 Old Bayshore Highway, Suite 400, Burlingame, California.
Why It Matters
This 8-K filing provides investors with updated financial information and operational results for Innoviva, Inc., crucial for assessing the company's performance and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting financial results and does not indicate any unusual or significant risks.
Key Players & Entities
- Innoviva, Inc. (company) — Registrant
- November 6, 2024 (date) — Date of earliest event reported
- 1350 Old Bayshore Highway, Suite 400, Burlingame, California 94010 (address) — Principal executive offices
- 650-238-9600 (phone_number) — Telephone number
FAQ
What specific financial information is being reported in this 8-K?
This 8-K filing pertains to the 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K filing submitted?
The filing was made on November 6, 2024.
What is the official name of the company filing this report?
The exact name of the registrant is Innoviva, Inc.
Where are Innoviva, Inc.'s principal executive offices located?
The principal executive offices are located at 1350 Old Bayshore Highway, Suite 400, Burlingame, California 94010.
What is the company's IRS Employer Identification Number?
The company's IRS Employer Identification Number is 94-3265960.
Filing Stats: 526 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2024-11-06 16:18:49
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share INVA The Nasdaq Stock Mar
Filing Documents
- tm2427621d1_8k.htm (8-K) — 24KB
- tm2427621d1_ex99-1.htm (EX-99.1) — 125KB
- tm2427621d1_ex99-1img01.jpg (GRAPHIC) — 10KB
- 0001104659-24-114800.txt ( ) — 343KB
- inva-20241106.xsd (EX-101.SCH) — 3KB
- inva-20241106_lab.xml (EX-101.LAB) — 33KB
- inva-20241106_pre.xml (EX-101.PRE) — 22KB
- tm2427621d1_8k_htm.xml (XML) — 4KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition On November 6, 2024, Innoviva, Inc. (the "Company") issued a press release regarding its results of operations and financial condition for the quarter ended September 30, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report. The information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits (d) Exhibits 99.1 Press Release dated November 6, 2024 104 Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document) - 2 - SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INNOVIVA, INC. Date: November 6, 2024 By: /s/ Pavel Raifeld Pavel Raifeld Chief Executive Officer - 3 -